PLANSPONSOR Roadmap: Health Benefit Fiduciary Duties—PBM Fact vs. Fiction

Influential figures outside the health benefit industry—such as President Donald Trump and businessman Mark Cuban— are making bold moves to improve access to and affordability of pharmaceuticals by directly contracting with the large pharmaceutical research and manufacturing companies. Experts will unpack the latest proposals and any potential impact on plan sponsors; explain how pharmacy benefit management works today; and outline the key actions sponsors should take to fulfill their fiduciary duties.